$35.7 Million is the total value of Tappan Street Partners LLC's 8 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 71.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PPHM | New | PEREGRINE PHARMACEUTICALS IN | $9,015,000 | – | 2,871,000 | +100.0% | 25.26% | – |
| ADNT | Sell | ADIENT PLC | $7,559,000 | +10.1% | 90,000 | -14.3% | 21.18% | +5.5% |
| VOYA | VOYA FINL INC | $6,582,000 | +8.1% | 165,000 | 0.0% | 18.44% | +3.6% | |
| HIL | Buy | HILL INTERNATIONAL INC | $4,418,000 | -5.6% | 930,000 | +3.3% | 12.38% | -9.6% |
| HDSN | Sell | HUDSON TECHNOLOGIES INC | $3,643,000 | -21.6% | 466,501 | -15.2% | 10.21% | -24.9% |
| REPH | New | RECRO PHARMA INC | $2,109,000 | – | 234,902 | +100.0% | 5.91% | – |
| ERII | New | ENERGY RECOVERY INC | $1,411,000 | – | 178,592 | +100.0% | 3.95% | – |
| GOOG | ALPHABET INCcap stk cl c | $959,000 | +5.5% | 1,000 | 0.0% | 2.69% | +1.1% | |
| SPA | Exit | SPARTON CORP | $0 | – | -180,000 | -100.0% | -11.57% | – |
| PPHM | Exit | PEREGRINE PHARMACEUTICALS INC | $0 | – | -11,593,530 | -100.0% | -20.61% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VOYA FINL INC | 8 | Q3 2017 | 18.5% |
| SPARTON CORP | 6 | Q2 2017 | 19.4% |
| BABCOCK & WILCOX ENTERPRIS I | 5 | Q4 2016 | 13.7% |
| SPIRIT AEROSYSTEMS HLDGS INC | 5 | Q4 2016 | 12.6% |
| BLUE BIRD CORP | 5 | Q1 2017 | 13.9% |
| ADIENT PLC | 4 | Q3 2017 | 22.8% |
| MCKESSON CORP | 4 | Q3 2016 | 13.7% |
| HUDSON TECHNOLOGIES INC | 4 | Q3 2017 | 13.6% |
| ITRON INC | 4 | Q3 2016 | 9.9% |
| SPARTON CORP | 4 | Q1 2017 | 7.5% |
View Tappan Street Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avid Bioservices, Inc. | October 28, 2021 | 2,181,379 | 3.6% |
| Blue Bird Corp | February 14, 2018 | 582,500 | 2.4% |
| SPARTON CORPSold out | February 14, 2018 | 0 | 0.0% |
| PEREGRINE PHARMACEUTICALS INC | November 13, 2017 | 3,829,504 | 8.5% |
View Tappan Street Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2021-10-28 |
| SC 13G/A | 2021-02-12 |
| SC 13G/A | 2020-02-14 |
| SC 13G/A | 2019-02-14 |
| SC 13G/A | 2018-02-14 |
| SC 13G/A | 2018-02-14 |
| SC 13G/A | 2018-02-14 |
| 13F-HR | 2017-11-14 |
| SC 13G/A | 2017-11-13 |
| 13F-HR | 2017-08-14 |
View Tappan Street Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.